Track the 앱클론 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 앱클론 has recorded 26 public disclosures. Market capitalisation: €557.9bn. The latest transaction was disclosed on 7 May 2026 (Purchase). Among the most active insiders: 쿼드자산운용. The full history is openly available.
25
Insider Decl.
n/a
Thresholds
€616,383
14 ops.
Buy Volume
n/a
8 ops.
Sell Volume
19Σ signal
Buys €616,383n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,850 of 28,102 companies
23.5
score / 100
Value
27
Quality
20
FCF yld-2.6%
Earn yld-3.2%
EV/EBITDA·
ROE-36%
Gross mgn24%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
AppClone is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for disease treatment.